- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03548441
Comparative Effectiveness and Prognostic Factors of Surgical and Non-surgical Management of Lumbar Spinal Stenosis
Comparative Effectiveness and Prognostic Factors for Outcome of Surgical and Non-surgical Management of Lumbar Spinal Stenosis in an Elderly Population: Protocol for an Observational Study
Introduction: Lumbar spinal stenosis is a common cause of low back and leg pain in elderly impacting physical activity and quality of life. Initial treatments are non-surgical options. If unsuccessful, surgery is advocated. The literature is not clear as to the outcome of surgery when compared to non-surgical treatment, and the optimal time for surgery is not explicit.
Materials and analysis: This observational study is designed to investigate the course of treatment, compare effectiveness of surgical and non-surgical treatment in patients with lumbar spinal stenosis, and identify prognostic factors for outcome in the context of current clinical practice. Prospectively registered data on treatment, outcome and patient characteristics are collected from nationwide registers on health and social issues, a clinical registry of people with chronic back pain and hospital medical records. Primary outcome is change in physical function measured by the Zurich Claudication Questionnaire. Secondary outcomes are changes in symptom severity, pain-related function, health-related quality of life, and general self-efficacy. All outcomes are measured at baseline, 6 months and 12 months follow up. Comparisons on these variables will be made between those who undergo surgery for lumbar spinal stenosis and those not receiving surgery at 12 months follow up according to different analysis populations. Prognostic factors include treatment allocation, back and leg pain intensity, comorbidity, duration of symptoms, pre-treatment function, self-rated health, income, general self-efficacy and magnetic resonance imaging graded compression of central stenosis.
Ethics and dissemination: The study has been evaluated by The Regional Committees on Health Research for Southern Denmark (S-20172000-200) and notified to the Danish Data Protection Agency (17/30636). All participants provide consent. Findings will be disseminated in peer-reviewed publications and presented at national and international conferences following the guidance from the STROBE and PROGRESS statement. Potential sources of bias will be addressed using ROBINS-I.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Helle A Brøgger, MSc
- Phone Number: +45 7266 2767
- Email: Helle.Algren.Brogger@rsyd.dk
Study Contact Backup
- Name: Berit Schiøttz-Christensen, PhD
- Phone Number: +45 2155 2927
- Email: Berit.Schiottz-Christensen@rsyd.dk
Study Locations
-
-
Fyn
-
Middelfart, Fyn, Denmark, 5500
- Recruiting
- Spine Centre of Souther Denmark
-
Contact:
- Helle A Brøgger, PhD student
- Phone Number: +45 7266 2767
- Email: Helle.Algren.Brogger@rsyd.dk
-
Contact:
- Berit Schiøttz-Christensen, Professor
- Phone Number: +45 2155 2927
- Email: Berit.Schiottz-Christensen@rsyd.dk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- >60 years.
- ICD-10 diagnosis of degenerative lumbar spinal stenosis registered in the nationwide patient registry between January 1st - December 31st 2017.
- Included in the SpineData registry.
- Give consent to use patient-reported data for research purposes
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Surgery
Exposed
|
Patients receiving surgical treatment undergo various types of posterior decompressive surgery with or without spinal fusion.
The method used for decompressive surgery or fusions is determined solely by the surgeon.
|
Non-surgical management
Non-exposed
|
Patients managing lumbar spinal stenosis non-surgically are either referred to rehabilitation primary health care center or referred back to their general practitioner for treatment.
Treatment may include physiotherapy, chiropractic treatment, lifestyle changes and/or pain management.
Post-surgically patients may also be referred to rehabilitation at a primary health care center.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Physical function
Time Frame: Between baseline and 12 months follow up
|
Change in physical function score in the Zurich Claudication Questionnaire (ZCQ) collected through a clinical registry of people with chronic back pain (SpineData). The ZCQ is a condition-specific self-reported measure of symptom severity, physical function and satisfaction with treatment in patients with lumbar spinal stenosis. The questionnaire is composed of three domains (subscales) with a Likert-type scale. The physical function subscale includes 6 items addressing walking distance and walking ability. All but one item have Likert response scales with 4 categories. The physical function subscale score is calculated from the unweighted mean of all answered items. The possible range of the score is 1 to 4. Lower scores indicate less disability. |
Between baseline and 12 months follow up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Symptom severity
Time Frame: Between baseline and 12 months follow up
|
Change in symptom severity score in the Zurich Claudication Questionnaire (ZCQ) collected through a clinical registry of people with chronic back pain (SpineData). The ZCQ is a condition-specific self-reported measure of symptom severity, physical function and satisfaction with treatment in patients with lumbar spinal stenosis. The questionnaire is composed of three domains (subscales) with a Likert-type scale. The symptom severity subscale includes 7 items addressing pain, numbness, weakness and balance disturbances. All but one item have Likert response scales with 5 categories. The possible range of the score is 1 to 5. Lower scores express less symptom severity. |
Between baseline and 12 months follow up
|
Pain related physical function
Time Frame: Between baseline and 12 months follow up
|
Change in Oswestry Disability Index collected through a clinical registry of people with chronic back pain (SpineData). The Oswestry Disability Index (ODI) is a region-specific questionnaire for assessing self-reported levels of disability for patients with spinal disorders. The questionnaire contains 10 pain related sections (items) with 6 response options (statements). Each section of six response options is scored from 0 (no pain) to 5 (most severe pain). For each section of six statements the total score is 5; if the first statement is marked, the score equals 0; if the last (6th) statement is marked, the score equals 5. If more than one box is marked in each section, the highest score is used. The section scores are summarised to a total score, ranging from 0-100. Scores are expressed as a percentage of total points. Lower scores indicate less disability. |
Between baseline and 12 months follow up
|
Health related quality of life
Time Frame: Between baseline and 12 months follow up
|
Change in health related quality of life measured by EQ-5D-3L collected through a clinical registry of people with chronic back pain (SpineData). The EQ-5D-3L is a generic self-reported instrument for measuring health-related quality of life consisting of a descriptive system and the EQ visual analogue scale (EQ VAS). The descriptive system comprises 5 dimensions (mobility, self-care, usual activities, pain/discomfort and anxiety/depression), each with 3 response options. These are converted into a single summary index by applying preference weights obtained from the general population with a total score ranging from -0.6 to 1, where 1 corresponds to perfect health and 0 to death. Higher scores indicate better health related quality of life, The EQ VAS is a vertical, visual analogue scale scoring patients self-rated health ranging from 0 (worst imaginable health state) to 100 (best imaginable health state). Higher scores indicate better self-perceived health. |
Between baseline and 12 months follow up
|
General self-efficacy
Time Frame: Between baseline and 12 months follow up
|
Change in general self-efficacy score obtained by the General Self Efficacy Scale collected through a clinical registry of people with chronic back pain (SpineData). The General Self efficacy scale is a self-reported unidimensional measure of general sense of perceived self-efficacy designed for the general adult population and used in patients with chronic pain. The questionnaire comprises of 10 items (statements) with 4 response options. Responses are scored on a 4-point Likert-scale from 1 (not true at all) to 4 (exactly true). Responses of all 10 items are summarised to yield the final composite score with a range from 10 - 40 points. Higher scores express greater perceived self-efficacy. |
Between baseline and 12 months follow up
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Diagnosis
Time Frame: At baseline
|
ICD-10 diagnosis codes collected from nationwide registers
|
At baseline
|
Age
Time Frame: At baseline
|
Potential prognostic factor / confounder collected from nationwide registers
|
At baseline
|
Sex
Time Frame: At baseline
|
Potential prognostic factor / confounder collected from nationwide registers
|
At baseline
|
Height
Time Frame: At baseline
|
Potential prognostic factor / confounder collected through a clinical registry of people with chronic back pain (SpineData)
|
At baseline
|
Weight
Time Frame: At baseline
|
Potential prognostic factor / confounder collected through a clinical registry of people with chronic back pain (SpineData)
|
At baseline
|
Cohabitation status
Time Frame: At baseline
|
Potential prognostic factor / confounder collected from nationwide registers
|
At baseline
|
Income
Time Frame: At baseline
|
Potential prognostic factor / confounder collected from nationwide registers
|
At baseline
|
Socio-economic classification
Time Frame: At baseline
|
Potential prognostic factor / confounder collected from nationwide registers
|
At baseline
|
Work status
Time Frame: At baseline
|
Potential prognostic factor / confounder collected from nationwide registers
|
At baseline
|
Highest level of education completed
Time Frame: At baseline
|
Potential prognostic factor / confounder collected from nationwide registers
|
At baseline
|
Number of consultations in primary health care centers
Time Frame: From baseline to 12 months follow up
|
Potential prognostic factor / confounder collected from nationwide registers
|
From baseline to 12 months follow up
|
Number of hospital admissions
Time Frame: From baseline to 12 months follow up
|
Potential prognostic factor / confounder collected from nationwide registers
|
From baseline to 12 months follow up
|
Use of prescriptive analgesic medicine
Time Frame: From baseline to 12 months follow up
|
Potential prognostic factor / confounder collected from nationwide registers
|
From baseline to 12 months follow up
|
Hospital department
Time Frame: From baseline to 12 months follow up
|
Potential prognostic factor / confounder collected from nationwide registers
|
From baseline to 12 months follow up
|
Duration of symptoms
Time Frame: At baseline
|
Potential prognostic factor / confounder collected through a clinical registry of people with chronic back pain (SpineData)
|
At baseline
|
Low back pain intensity
Time Frame: From baseline to 12 months follow up
|
Change in Numerical Pain Rating Scale (NPRS) as Potential prognostic factor / confounder collected through a clinical registry of people with chronic back pain (SpineData). The Numeric Pain Rating Scale (NPRS) is an 11-point, unidimensional measure of pain intensity in which patients rate their pain ranging from 0 (no pain) to 10 (worst pain imaginable). Lower scores indicate less pain. |
From baseline to 12 months follow up
|
Leg pain intensity
Time Frame: From baseline to 12 months follow up
|
Change in Numerical Pain Rating Scale (NPRS) as potential prognostic factor / confounder collected through a clinical registry of people with chronic back pain (SpineData). The Numeric Pain Rating Scale (NPRS) is an 11-point, unidimensional measure of pain intensity in which patients rate their pain ranging from 0 (no pain) to 10 (worst pain imaginable). Lower scores indicate less pain. |
From baseline to 12 months follow up
|
Comorbidity
Time Frame: From baseline to 12 months follow up
|
Charlson comorbidity index as potential prognostic factor / confounder collected from nationwide registers. The Charlson Comorbidity Index is a method of categorising comorbidities of patients based on the International Classification of Diseases (ICD) diagnosis codes found in administrative data, such as a national patient registry. Each comorbidity category has an associated weight (from 1 to 6), based on the relative risk of 1-year mortality. The sum of all the weights results in a single comorbidity score for a patient. An index score of 0 indicates that no comorbidities were found. A higher index score indicates a higher risk of death within 1 year. |
From baseline to 12 months follow up
|
Degree of central stenosis
Time Frame: At baseline
|
Potential prognostic factor / confounder collected from Magnetic Resonance Imaging (MRI) descriptions in hospital medical records. MRI graded compression is estimated using a classification ranging from mild to moderate or severe stenosis. Mild stenosis is defined as narrowing of one-third of the normal area or less, moderate stenosis as narrowing of between one- and two-thirds, and severe stenosis as narrowing of more than two-thirds of the area. |
At baseline
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Helle A Brøgger, MSc, 1) Spine Centre of Southern Denmark, 2) University of Southern Denmark, 3) The Parker Research Institute, 4) University College South Denmark
- Study Director: Robin Christensen, PhD, 1) The Parker Research Institute 2) Odense University Hospital
- Study Director: Thomas Maribo, PhD, 1) Aarhus University 2) DEFACTUM
- Study Chair: Berit Schiøttz-Christensen, PhD, 1) Spine Centre of Southern Denmark, 2) University of Southern Denmark
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 17/30636
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lumbar Spinal Stenosis
-
Johns Hopkins UniversityNorth American Spine SocietyCompletedLumbar Spinal Stenosis | Lumbar Spine Degeneration | Lumbar Spinal InstabilityUnited States
-
Azienda Usl di BolognaRecruitingLumbar Spinal Stenosis | Degenerative Lumbar Spinal StenosisItaly
-
Medipol UniversityWithdrawnLumbar Spinal Stenosis | Lumbar Disc Disease | Lumbar Spine Degeneration | Lumbar Spine InstabilityTurkey
-
University Hospital, Basel, SwitzerlandKlinik für Radiologie und Nuklearmedizin, University Hospital BaselCompletedLumbar Spinal Stenosis | Symptomatic Lumbar Spinal StenosisSwitzerland
-
Bursa City HospitalCompletedLumbar Spinal Stenosis | Lumbar Spine Degeneration | Lumbar Spine InstabilityTurkey
-
Xuanwu Hospital, BeijingRecruitingLumbar Disc Herniation | Lumbar Spinal Stenosis | Lumbar SpondylosisChina
-
Neurocenter of Southern SwitzerlandMaastricht University; Schulthess KlinikRecruitingLumbar Spinal Stenosis | Lumbar Spondylolisthesis | Spinal Disease | Lumbar InstabilitySwitzerland
-
University of Roma La SapienzaRecruitingLumbar Spinal Stenosis | Lumbar Spondylolisthesis | Lumbar Spine Degeneration | Lumbar Spine InstabilityItaly
-
Cantonal Hospital of St. GallenProf. Dr. Astrid Weyerbrock, Klinik für Neurochirurgie, Kantonsspital St.... and other collaboratorsCompletedLumbar Spinal Stenosis | Lumbar Disc Disease | Lumbar Spine DegenerationSwitzerland
-
Kyungpook National University HospitalCompletedDisk Herniated Lumbar | Spinal Stenosis LumbarKorea, Republic of
Clinical Trials on Surgery
-
University of AarhusCompletedAcute Post Operative Pain | Chronic Postsurgical PainDenmark
-
International Study Group on Minimally Invasive...Fondazione CARIT; LOGIX S.r.l.Unknown
-
Peking Union Medical College HospitalCompletedPancreatic Neuroendocrine TumorsChina
-
Hospital Central de la Defensa Gómez UllaClinica Universidad de Navarra, Universidad de NavarraEnrolling by invitationRectal Cancer | PROM | Functional Bowel DisorderSpain
-
Sunnybrook Health Sciences CentreMcMaster University; Unity Health Toronto; University of Toronto; University of... and other collaboratorsCompleted
-
Shanghai Zhongshan HospitalUnknownCarcinoma, Pancreatic Ductal | Circulating Tumor CellsChina
-
The Second Hospital of Shandong UniversityRecruitingLung Diseases | SurgeryChina
-
Federal University of São PauloUnknownObesity | LymphedemaBrazil
-
The Christie NHS Foundation TrustUniversity of ManchesterRecruitingQuality of Life | Lung NeoplasmsUnited Kingdom
-
Spinal Surgery Clinic, SträngnäsCompletedLow Back Pain | Pelvic Pain